February 25, 2022 – Dignity Health in Arizona is launching the first research study in North America in which genetic testing is used to identify men and women at risk of developing  heart disease based on the makeup of their DNA. If proven effective in clinical trials, this form of genetic testing may be adopted globally to prevent heart disease. Heart disease is the No. 1 killer in the world – in fact, half of Americans are expected to have at least one cardiac event in their lifetime.  

February 24, 2022 — The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.

February 24, 2022 — The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil lawsuit today to stop UnitedHealth Group Incorporated (United) from acquiring Change Healthcare Inc. (Change). The complaint, filed in the U.S.

February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you sign in with your doctor using facial recognition or a fingerprint scanner; thanks to an efficient digital system, your doctor instantly pulls files with all your medical history; and once a treatment is decided, the prescription is automatically delivered to your bedside—all of this with full transparency, from scheduling to diagnosis, prescription and payment.

February 21, 2022 – The human gut contains trillions of bacteria, collectively called the gut microbiome, which may have positive and negative effects on human health. When in balance they function as an inner chemistry factory producing numerous compounds that promote good health.

February 21, 2022—Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts. For most children, the precise causes of these frightening defects are unknown.

February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, has revealed for the first time that the thrombus generated by ulcerated plaque (UP) observed in the femoropopliteal artery (FPA) during angioscopy is the source of embolization of the popliteal artery.

February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and mortality in the U.S. and Europe. About 80 percent of those events occur because a build-up of plaque in the arteries—or atherosclerotic plaque (AP)—ruptures.

February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now